Clinical Trial Update: A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas [Phase 1, Phase 2]

View source ↗

Summary

A platform trial evaluating new drugs or drug combinations in relapsed/refractory peripheral T-cell lymphoma is currently recruiting for Phase 1 and Phase 2 coh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Snippet

Sponsor: The Lymphoma Academic Research Organisation | Conditions: Peripheral T Cells Lymphoma (PTCL) | Phase 1, Phase 2 | Status: RECRUITING